» Articles » PMID: 20536174

Well-defined, Size-tunable, Multifunctional Micelles for Efficient Paclitaxel Delivery for Cancer Treatment

Overview
Journal Bioconjug Chem
Specialty Biochemistry
Date 2010 Jun 12
PMID 20536174
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a well-defined and biocompatible amphiphilic telodendrimer system (PEG-b-dendritic oligo-cholic acid) which can self-assemble into multifunctional micelles in aqueous solution for efficient delivery of hydrophobic drugs such as paclitaxel. In this telodendrimer system, cholic acid is essential for the formation of stable micelles with high drug loading capacity, owing to its facial amphiphilicity. A series of telodendrimers with variable length of PEG chain and number of cholic acid in the dendritic blocks were synthesized. The structure and molecular weight of each of these telodendrimers were characterized, and their critical micellization concentration (CMC), drug-loading properties, particle sizes, and cytotoxicity were examined and evaluated for further optimization for anticancer drug delivery. The sizes of the micelles, with and without paclitaxel loading, could be tuned from 11.5 to 21 nm and from 15 to 141 nm, respectively. Optical imaging studies in xenograft models demonstrated preferential uptake of the smaller paclitaxel-loaded micelles (17-60 nm) by the tumor and the larger micelles (150 nm) by the liver and lung. The toxicity and antitumor efficacy profiles of these paclitaxel-loaded micelles in xenograft models were found to be superior to those of Taxol and Abraxane.

Citing Articles

Surface Immobilization of Anti-VEGF Peptide on SPIONs for Antiangiogenic and Targeted Delivery of Paclitaxel in Non-Small-Cell Lung Carcinoma.

Ngema L, Adeyemi S, Marimuthu T, Ubanako P, Ngwa W, Choonara Y ACS Appl Bio Mater. 2023; 6(7):2747-2759.

PMID: 37384895 PMC: 10354746. DOI: 10.1021/acsabm.3c00224.


Stimuli-responsive crosslinked nanomedicine for cancer treatment.

Xue X, Qu H, Li Y Exploration (Beijing). 2023; 2(6):20210134.

PMID: 37324805 PMC: 10190936. DOI: 10.1002/EXP.20210134.


Cisplatin and paclitaxel co-delivery nanosystem for ovarian cancer chemotherapy.

Wang Q, Wu C, Li X, Yang D, Shi L Regen Biomater. 2022; 8(3):rbab015.

PMID: 35707698 PMC: 8240646. DOI: 10.1093/rb/rbab015.


Novel nanococktail of a dual PI3K/mTOR inhibitor and cabazitaxel for castration-resistant prostate cancer.

Huang Y, Xue X, Li X, Jia B, Pan C, Li Y Adv Ther (Weinh). 2020; 3(10).

PMID: 33072858 PMC: 7567330. DOI: 10.1002/adtp.202000075.


Telodendrimers: Promising Architectural Polymers for Drug Delivery.

Mejlsoe S, Kakkar A Molecules. 2020; 25(17).

PMID: 32887285 PMC: 7504730. DOI: 10.3390/molecules25173995.


References
1.
Luo J, Giguere G, Zhu X . Asymmetric poly(ethylene glycol) star polymers with a cholic acid core and their aggregation properties. Biomacromolecules. 2009; 10(4):900-6. DOI: 10.1021/bm801423p. View

2.
Oku . Anticancer therapy using glucuronate modified long-circulating liposomes. Adv Drug Deliv Rev. 2000; 40(1-2):63-73. DOI: 10.1016/s0169-409x(99)00040-x. View

3.
Xiao K, Luo J, Fowler W, Li Y, Lee J, Xing L . A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Biomaterials. 2009; 30(30):6006-16. PMC: 2735593. DOI: 10.1016/j.biomaterials.2009.07.015. View

4.
Gillies E, Frechet J . pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem. 2005; 16(2):361-8. DOI: 10.1021/bc049851c. View

5.
Janout V, Regen S . Bioconjugate-based molecular umbrellas. Bioconjug Chem. 2008; 20(2):183-92. PMC: 2674025. DOI: 10.1021/bc800296g. View